Phosphorylation of the 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase/PFKFB3 family of glycolytic regulators in human cancer

Clinical Cancer Research

Volumn 11, Issue 16, 2005, Pages 5784-5792

  Bando, Hidenori ^a   Atsumi, Toshiya ^a   Nishio, Taro ^a   Niwa, Hirokatsu ^a   Mishima, Shinya ^a   Shimizu, Chikara ^a   Yoshioka, Narihito ^a   Bucala, Richard ^b   Koike, Takao ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 PHOSPHOFRUCTO 2 KINASE; ANTIBODY; COMPLEMENTARY DNA; FRUCTOSE 2,6 BISPHOSPHATASE; GENE PRODUCT; GLUTAMIC ACID; ISOPROTEIN; LACTIC ACID; MESSENGER RNA; PFKB3 ACG PROTEIN; PFKB3 AG PROTEIN; PFKFB3 PROTEIN; PHOSPHOPROTEIN; REGULATOR PROTEIN; SERINE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANGIOGENESIS; ANIMAL CELL; ARTICLE; CANCER; CANCER CELL CULTURE; CARCINOGENESIS; CELL PROLIFERATION; CELL STRAIN COS7; COLON CARCINOMA; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GLYCOLYSIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NONHUMAN; PFKFB1 GENE; PFKFB3 GENE; PFKFB4 GENE; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; PROTEIN VARIANT; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; VASCULAR ENDOTHELIUM;

ALTERNATIVE SPLICING; ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CERCOPITHECUS AETHIOPS; COS CELLS; CULTURE MEDIA; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOLYSIS; HUMANS; ISOENZYMES; JURKAT CELLS; MICE; MUTATION; NEOPLASMS; OLIGOMYCINS; PHOSPHOFRUCTOKINASE-2; PHOSPHORYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION; U937 CELLS;

EID: 23844517036     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-05-0149     Document Type: Article

References (38)

1. Warburg O. On the origin of cancer cells. Science 1956;723:309-14.
2. Van Schaftingen E, Jett MF, Hue L, Hers HG. Control of liver 6-phosphofructokinase by fructose 2,6-bisphosphate and other effectors. Proc Natl Acad Sci U S A 1981;78:3483-6.
3. Hue L, Rousseau GG. Fructose 2,6-bisphosphate and the control of glycolysis by growth factors, tumor promoters and oncogenes. Adv Enzyme Regul 1993;33:97-110.
4. Nissler K, Petermann H, Wenz I, Brox D. Fructose 2,6-bisphosphate metabolism in Ehrlich ascites tumour cells. J Cancer Res Clin Oncol 1995;121:739-45.
5. Mojena M, Bosca L, Hue L. Effect of glutamine on fructose 2,6-bisphosphate and on glucose metabolism in HeLa cells and in chick-embryo fibroblasts. Biochem J 1985;232:521-7.
6. Miralpeix M, Azcon-Bieto J, Bartrons R, Argiles JM. The impairment of respiration by glycolysis in the Lewis lung carcinoma. Cancer Lett 1990;50:173-8.
7. Okar DA, Manzano A, Navarro-Sabate A, Riera L, Bartrons R, Lange AJ. PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2,6-bisphosphate. Trends Biochem Sci 2001;26:30-5.
8. Manzano A, Perez JX, Nadal M, Estivill X, Lange A, Bartrons R. Cloning, expression and chromosomal localization of a human testis 6-phosphofructo-2- kinase/fructose-2,6-bisphosphatase gene. Gene 1999;229:83-9.
9. Heine-Suner D, Diaz-Guillen MA, Lange AJ, Rodriguez de Cordoba S. Sequence and structure of the human 6-phosphofructo-2-kinase/fructose-2,6- bisphosphatase heart isoform gene (PFKFB2). Eur J Biochem 1998;254:103-10.
10. Lange AJ, Pilkis SJ. Sequence of human liver 6-phosphofructo-2-kinase/ fructose-2,6-bisphosphatase. Nucleic Acids Res 1990;18:3652.
11. El-Maghrabi MR, Pilkis SJ. Rat liver 6-phosphofructo 2-kinase/fructose 2,6-bisphosphatase: a review of relationships between the two activities of the enzyme. J Cell Biochem 1984;26:1-17.
12. Chesney J, Mitchell R, Benigni F, et al. An inducible gene product for 6-phosphofructo-2-kinase with an AU-rich instability element: role in tumor cell glycolysis and the Warburg effect. Proc Natl Acad Sci U S A 1999;96:3047-52.
13. Mahlknecht U, Chesney J, Hoelzer D, Bucala R. Cloning and chromosomal characterization of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 gene (PFKFB3, iPFK2). Int J Oncol 2003;23:883-91.
14. Nicholl J, Hamilton JA, Sutherland GR, Sutherland RL, Watts CK. The third human isoform of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB3) map position 10p14-p15. Chromosome Res 1997;5:150.
15. Sakakibara R, Kato M, Okamura N, et al. Characterization of a human placental fructose-6-phosphate, 2-kinase/fructose-2,6-bisphosphatase. J Biochem (Tokyo) 1997;122:122-8.
16. Shaw G, Kamen R. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 1986;46:659-67.
17. Atsumi T, Chesney J, Metz C, et al. High expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (iPFK-2; PFKFB3) in human cancers. Cancer Res 2002;62:5881-7.
18. Kessler R, Eschrich K. Splice isoforms of ubiquitous 6-phosphofructo-2- kinase/fructose-2,6-bisphosphatase in human brain. Brain Res Mol Brain Res 2001;87:190-5.
19. Manzano A, Rosa JL, Ventura F, et al. Molecular cloning, expression, and chromosomal localization of a ubiquitously expressed human 6-phosphofructo-2- kinase/fructose-2,6-bisphosphatase gene (PFKFB3). Cytogenet Cell Genet 1998;83:214-7
20. Sakai A, Kato M, Fukasawa M, Ishiguro M, Furuya E, Sakakibara R. Cloning of cDNA encoding for a novel isozyme of fructose 6-phosphate, 2-kinase/fructose 2,6-bisphosphatase from human placenta. J Biochem (Tokyo) 1996;119:506-11.
21. Ventura F, Ambrosio S, Bartrons R, el-Maghrabi MR, Lange AJ, Pilkis SJ. Cloning and expression of a catalytic core bovine brain 6-phosphofructo-2- kinase/fructose-2,6-bisphosphatase. Biochem Biophys Res Commun 1995;209:1140-8.
22. Watanabe F, Sakai A, Furuya E. Novel isoforms of rat brain fructose 6-phosphate 2-kinase/fructose 2,6-bisphosphatase are generated by tissue-specific alternative splicing. J Neurochem 1997;69:1-9.
23. Marsin AS, Bouzin C, Bertrand L, Hue L. The stimulation of glycolysis by hypoxia in activated monocytes is mediated byAMP-activated protein kinase and inducible 6-phosphofructo-2-kinase. J Biol Chem 2002;277:30778-83.
24. Deprez J, Vertommen D, Alessi DR, Hue L, Rider MH, Phosphorylation and activation of heart 6-phosphofructo-2-kinase by protein kinase B and other protein kinases of the insulin signaling cascades. J Biol Chem 1997;272:17269-75.
25. Van Schaftingen E, Lederer B, Bartrons R, Hers HG. A kinetic study of pyrophosphate: fructose-6-phosphate phosphotransferase from potato tubers. Application to a microassay of fructose 2,6-bisphosphate. Eur J Biochem 1982;129:191-5.
26. Lang CH, Bagby GJ, Spitzer JJ. Glucose kinetics and body temperature after lethal and nonlethal doses of endotoxin. Am J Physiol 1985;248:R471-8.
27. Orlinska U, Newton RC. Role of glucose in interleukin-1 β production by lipopolysaccharide-activated human monocytes. J Cell Physiol 1993;157:201-8.
28. Guida E, Stewart A. Influence of hypoxia and glucose deprivation on tumour necrosis factor-α and granulocyte-macrophage colony-stimulating factor expression in human cultured monocytes. Cell Physiol Biochem 1998;8:75-88.
29. Joaquin M, Salvado C, Bellosillo B, Lange AJ, Gil J, Tauler A. Effect of growth factors on the expression of 6-phosphofructo-2-kinase/fructose-2,6- bisphosphatase in Rat-1 fibroblasts. J Biol Chem 1997;272:2846-51.
30. Fukasawa M, Takayama E, Shinomiya N, et al. Identification of the promoter region of human placental 6-phosphofructo-2-kinase/fructose-2,6- bisphosphatase gene. Biochem Biophys Res Commun 2000;267:703-8.
31. Dang CV, Semenza GL. Oncogenic alterations of metabolism. Trends Biochem Sci 1999;24:68-72.
32. Firth JD, Ebert BL, Pugh CW, Ratcliffe PJ. Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3′ enhancer. Proc Natl Acad Sci U S A 1994;91:6496-500.
33. Semenza GL, Jiang BH, Leung SW, et al. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 1996;271:32529-37.
34. Flier JS, Mueckler MM, Usher P, Lodish HF. Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science 1987;235:1492-5.
35. Birnbaum MJ, Haspel HC, Rosen OM. Transformation of rat fibroblasts by FSV rapidly increases glucose transporter gene transcription. Science 1987;235:1495-8.
36. Minchenko A, Leshchinsky I, Opentanova I, et al. Hypoxia-inducible factor-1-mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6- bisphosphatase-3 (PFKFB3) gene. Its possible role in the Warburg effect. J Biol Chem 2002;277:6183-7.
37. Kato K, Ogura T, Kishimoto A, et al. Critical roles of AMP-activated protein kinase in constitutive tolerance of cancer cells to nutrient deprivation and tumor formation. Oncogene 2002;21:6082-90.
38. Maschek G, Savaraj N, Priebe W, et al. 2-Deoxy-D-glucose increases the efficacy of Adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo. Cancer Res 2004;64:31-4.